aiSwingX™ analyzes US filings and reports them as news investors can read.
–
0 1
Filing fact · AMGN · 10-Q · 2026-08-04

Cash

Amgen Inc. (AMGN) reported Cash of USD 13,989,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).

PeriodValueVerify
2026-06-30 $13,989,000,000 EDGAR ↗
2025-12-31 (comparative) $9,129,000,000 EDGAR ↗

Provenance

Company Amgen Inc. · CIK 318154
Form 10-Q · Accession 0000318154-26-000126 · Filed 2026-08-04
XBRL tag us-gaap:CashAndCashEquivalentsAtCarryingValue · unit USD · instant

Values are read directly from the inline XBRL the company filed with EDGAR. The EDGAR links above point to the exact figure inside the filing document. No ratios or interpretation are added here.

Cite this

Amgen Inc. (AMGN) reported Cash of USD 13,989,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).
— aiSwingX, https://aiswingx.com/n/0000318154-26-000126/CashAndCashEquivalentsAtCarryingValue

JSON: /api/v1/facts/0000318154-26-000126/CashAndCashEquivalentsAtCarryingValue

aiSwingX™ analyzes US filings and reports them as news investors can read.
–
0 1